Literature DB >> 8095453

Treatment of Raynaud's phenomenon.

H Wollersheim, P A van Zwieten.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8095453     DOI： 10.1093/eurheartj/14.2.147

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

Review 1.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

2.  Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.

Authors:  L La Civita; D Giuggioli; M G Del Chicca; G Longombardo; G Pasero; C Ferri
Journal:  Ann Rheum Dis       Date:  1996-05       Impact factor: 19.103

3.  Preliminary Report of Endovascular Treatment for Critical Limb Ischemia Patients with Connective Tissue Disease: Cases Series and Review of the Literature.

Authors:  Hideaki Obara; Kentaro Matsubara; Naoki Fujimura; Yasuhito Sekimoto; Yuko Kitagawa
Journal:  Int J Angiol       Date:  2015-06

4.  Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon.

Authors:  Yasuyuki Kamata; Seiji Minota
Journal:  Rheumatol Int       Date:  2014-05-01       Impact factor: 2.631
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.